Hawaii Birth Defects Registry: Privacy Guidelines for Perinatal Quality Programs Submitting Congenital Anomaly Reports

Overview of Hawaii Birth Defects Program

The Hawaii Birth Defects Registry supports a statewide birth defects surveillance system that tracks congenital anomalies from prenatal diagnosis through early childhood. Its mission is to inform prevention, improve clinical outcomes, and guide public health policy while upholding patient data confidentiality.

Perinatal quality programs play a central role by submitting accurate, timely congenital anomaly reporting from hospitals, birthing centers, neonatal units, specialty clinics, and laboratories. Your submissions enable complete case ascertainment, trend analysis, and quality improvement that directly benefit mothers, infants, and families.

This guidance explains how to submit reports in line with the Hawaii Birth Defects Registry privacy expectations. It summarizes legal foundations, required data elements, safeguards for protected health information, and practical steps to maintain compliance.

Legal Authority and Statutory Requirements

State law authorizes the collection and use of birth defects data for public health surveillance and program evaluation. Key provisions include Hawaiʻi Revised Statutes §321-422, which supports perinatal and child health initiatives, and Hawaiʻi Revised Statutes §324-42 and §324-43, which govern confidentiality, security, and permissible release of health-related data.

These statutes allow the Department of Health and its birth defects surveillance system to receive reports from covered entities for public health purposes while limiting disclosure to what is necessary and lawful. They reinforce patient privacy, mandate secure handling, and restrict re-disclosure without proper authority.

Reporting must also align with federal standards such as the HIPAA Privacy Rule’s minimum necessary principle. When state and federal requirements both apply, follow the most protective standard. This document offers operational guidance and does not substitute for legal advice—consult your compliance or legal counsel for interpretations specific to your organization.

Data Collection Procedures

What to report

Report confirmed or strongly suspected structural or chromosomal anomalies identified prenatally, at delivery, during the newborn hospitalization, or in early childhood follow-up. Include sufficient clinical detail to support surveillance, quality review, and deduplication while limiting extraneous identifiers.

• Infant identifiers used for linkage (for example, name, date of birth, medical record number) and, when relevant, maternal identifiers for mother-infant matching.
• Clinical diagnosis details (anomaly name, ICD-10-CM or SNOMED codes, laterality, severity, and diagnostic method such as ultrasound, echocardiography, genetic testing, or pathology).
• Pregnancy and birth information (gestational age, plurality, birth weight, delivery facility, and outcome).
• Contextual factors needed for surveillance (for example, prenatal exposures or procedures if documented in the medical record).

When to report

Submit reports promptly after confirmation and within timelines communicated by the Department of Health program. Update prior submissions if diagnoses are refined, additional anomalies are identified, or outcomes change during follow-up.

How to submit

• Use the secure submission channels designated by the program (for example, encrypted portal or secure file transfer) and avoid email for protected data.
• Package records in the program’s required format, using standardized codes and data dictionaries to ensure interoperability and accurate case matching.
• Validate files before transmission, resolve schema or logic errors, and retain your transmission receipts for audit purposes.

Privacy and Confidentiality Protections

Protecting patient data confidentiality is foundational. Access to personally identifiable information is restricted to authorized public health personnel with a legitimate need, and only the minimum necessary data are collected and used to fulfill surveillance objectives.

Direct identifiers are kept separate from analytic datasets whenever practical, with unique keys supporting linkage and deduplication. Audit logs, role-based access control, and workforce training reinforce accountability and appropriate use.

Security controls apply across the data life cycle—collection, transmission, storage, analysis, retention, and disposition. Encryption in transit and at rest, secure key management, and physical safeguards (for example, restricted server rooms) protect records from unauthorized access or alteration.

Use of De-Identified Data

The registry produces de-identified and aggregate outputs to inform prevention and quality improvement while preventing re-identification. De-identified datasets exclude or transform direct identifiers and limit indirect identifiers, enabling broader use for surveillance, research, and program evaluation.

• Apply recognized de-identification approaches (for example, safe-harbor style removal of direct identifiers or expert determination with documented risk assessment).
• Aggregate small cells, coarsen dates or geography when needed, and suppress combinations that could enable identity inference.
• Share only as permitted by Hawaiʻi Revised Statutes §324-42 and §324-43, and under data use agreements that prohibit re-identification or unauthorized linkage.

Reporting Responsibilities of Healthcare Providers

Healthcare facilities, clinicians, and perinatal quality programs are responsible for complete and timely reporting of eligible cases within their scope of care. This includes diagnoses made in obstetric care, neonatal intensive care, pediatric specialty clinics, genetic services, and pathology or laboratory settings.

• Confirm that the case meets program criteria and capture the clearest available diagnosis using standardized terminology and codes.
• Include supporting clinical documentation (for example, imaging or genetic test summaries) when required by the program’s specification.
• Transmit via approved secure methods and maintain local logs of what was submitted and when.
• Correct errors discovered post-submission and submit follow-up updates as outcomes evolve.
• Educate frontline staff on workflow steps so that congenital anomaly reporting is integrated into discharge and follow-up processes.

Your diligence enhances data quality and ensures that statewide metrics reflect true burden and disparities, informing targeted interventions and resource allocation.

Strategies for Data Security and Compliance

Strong governance and layered safeguards reduce risk and support continuous compliance. Establish clear roles for data stewardship, privacy oversight, and incident response, and review these assignments at least annually.

Technical and administrative controls

• Use multi-factor authentication, role-based permissions, and timely deprovisioning for users who change roles.
• Encrypt all transmissions and stored files; employ secure key management and vetted cryptographic libraries.
• Implement data minimization, retention schedules, and defensible destruction procedures.
• Provide recurring workforce training on confidentiality, secure handling, and phishing awareness.

Vendor and interoperability safeguards

• Execute appropriate agreements (for example, business associate or data sharing agreements) specifying security requirements, breach notification, and limits on use.
• Exchange data using standards-based formats and validate conformance before onboarding or version upgrades.

Monitoring and incident response

• Log access and changes, review anomalies, and perform periodic risk assessments with remediation plans.
• Maintain an incident response plan with defined timelines for containment, investigation, notification, and post-incident review.

Conclusion

The Hawaii Birth Defects Registry: Privacy Guidelines for Perinatal Quality Programs Submitting Congenital Anomaly Reports emphasize lawful collection, minimum necessary use, and robust safeguards from intake to publication. By reporting accurately, securing data at every step, and applying disciplined de-identification, you help protect families’ privacy while advancing prevention and perinatal quality across Hawaiʻi.

FAQs.

What privacy protections are in place for birth defects data?

The program restricts access to authorized personnel, applies the minimum necessary standard, separates direct identifiers from analytic files, and uses encryption, audit logging, and role-based access. Policies align with Hawaiʻi Revised Statutes §324-42 and §324-43 and incorporate HIPAA-aligned safeguards.

How does the Hawaii Birth Defects Program use collected information?

Collected information supports the birth defects surveillance system, quality improvement, prevention strategies, and public health reporting. Public outputs are de-identified and aggregated to protect individuals while highlighting trends, disparities, and opportunities for intervention.

What are healthcare providers’ reporting obligations?

Providers and perinatal quality programs must report eligible congenital anomalies promptly, supply required clinical details, transmit via approved secure channels, and send corrections or updates as new information emerges. Follow the Department of Health’s specifications for formats and timelines.

How is personally identifiable information handled in congenital anomaly reports?

Personally identifiable information is collected only as needed for linkage and deduplication, stored securely with restricted access, and excluded from public releases. When data are shared for secondary use, the program applies de-identification and data use agreements that prohibit re-identification or unauthorized disclosure.